Healthcare

Eli Lilly and Company is showcasing a multi-faceted growth strategy, with recent developments underscoring that its expansion is not solely...

ProPhase Labs is undergoing a significant portfolio review, with the potential sale of core business units now under consideration. The...

IMAC Holdings is undergoing a significant corporate transformation, fundamentally shifting its core business model. The company is moving away from...

The primary objective for 22nd Century Group remains clear: reaching profitability by 2026. The company is intensifying efforts to scale...

BridgeBio Pharma announced yesterday the successful completion of the pivotal Phase 3 PROPEL 3 study evaluating Infigratinib. The data demonstrate...

Intuitive Surgical finds itself at an interesting juncture, with recent insider transactions and a tempered growth outlook drawing investor scrutiny...

While Eli Lilly continues to generate headlines and record earnings with its blockbuster weight-loss drugs, the pharmaceutical giant's leadership is...

A notable new institutional position has been disclosed in medical device firm enVVeno Medical. Recent regulatory filings reveal that Braeden...

Ekso Bionics Holdings is entering what could be a transformative first half of 2026. The company stands at a critical...

As of February 2026, the two biotech pioneers synonymous with the mRNA-based COVID-19 vaccine rollout, Moderna and BioNTech, face a...